Logo CICANCER

Old CIC Events

STOP RAS CANCERS. Program on Early Diagnosis and Targeted Intervention for RAS-driven Cancers? 23/05/2023

STOP RAS CANCERS. Program on Early Diagnosis and Targeted Intervention for RAS-driven Cancers?

David Santamaría — Centro de Investigación del Cáncer (CSIC-Universidad de Salamanca), Salamanca

TGF-beta and NADPH oxidases: a perverse association in liver fibrosis and cancer 11/05/2023

TGF-beta and NADPH oxidases: a perverse association in liver fibrosis and cancer

Isabel Fabregat — Bellvitge Biomedical Research Institute, IDIBELL, Barcelona

Servicio de Patología Molecular Comparada del CIC 21/04/2023

Servicio de Patología Molecular Comparada del CIC

Equipo de PMC — Centro de Investigación del Cáncer, Salamanca

How does DNA replication initiate in animal cells? 20/04/2023

How does DNA replication initiate in animal cells?

Karim Labib — University of Dundee, Dundee, UK

EMT and plasticity trajectories in development and disease 13/04/2023

EMT and plasticity trajectories in development and disease

Ángela Nieto — Instituto de Neurociencias (CSIC-UMH), Alicante, Spain

N6-ADENOSINE METHYLTRANSFERASE COMPLEX REGULATOR ZC3H13 DELETION AS MALIGNANT PROGNOSIS FACTOR IN PROSTATE CANCER 30/03/2023

N6-ADENOSINE METHYLTRANSFERASE COMPLEX REGULATOR ZC3H13 DELETION AS MALIGNANT PROGNOSIS FACTOR IN PROSTATE CANCER

Óscar Monteagudo — Epitranscriptomic and Cancer Lab, Centro de Investigación del Cáncer (CIC)

Functions of METTL3 in stem cells and cancer 23/03/2023

Functions of METTL3 in stem cells and cancer

Francesca Aguilo — Umea University, Sweden

Specific killing of BRCA1-deficient cancer cells by depletion of EXO1 16/03/2023

Specific killing of BRCA1-deficient cancer cells by depletion of EXO1

Haico van Attikum — Department of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands

RAS-p110a signalling controls macrophage-derived inflammatory response by favouring transendothelial migration and phagocytic capacity. 09/03/2023

RAS-p110a signalling controls macrophage-derived inflammatory response by favouring transendothelial migration and phagocytic capacity.

Alejandro Rosell Jiménez — Centro de Investigación del Cáncer (CSIC-USAL), Salamanca